AI assistant
CleanGo Innovations Inc. — Interim / Quarterly Report 2021
Aug 27, 2021
47310_rns_2021-08-27_c5e5cac8-e649-4992-a7ed-0ddca359aa2e.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
SOFTLAB9 TECHNOLOGIES INC.
Condensed Consolidated Financial Statements Six Months Ended June 30, 2021 and 2020
(Expressed in Canadian dollars)
(unaudited)
Softlab9 Technologies Inc.
Condensed Consolidated Statements of Financial Position (Expressed in Canadian dollars)
| Softlab9 Technologies Inc. Condensed Consolidated Statements of Financial Position (Expressed in Canadian dollars) |
||
|---|---|---|
| June 30, | December 31, | |
| 2021 | 2020 | |
| $ | $ | |
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash | 43,739 | 141,134 |
| Amounts receivable | 126,017 | 109,702 |
| Prepaid expenses and deposits | 5,000 | 37,000 |
| Loans receivable (Note 3) | 978,526 | 948,426 |
| TOTAL ASSETS | 1,153,282 | 1,236,262 |
| LIABILITIES | ||
| CURRENT LIABILITIES | ||
| Accounts payable and accrued liabilities (Note 8) | 1,038,420 | 770,419 |
| Loans payable (Note 4) | 99,730 | 99,730 |
| Due to related parties (Note 8) | 28,031 | 28,031 |
| TOTAL LIABILITIES | 1,166,181 | 898,180 |
| SHAREHOLDERS' EQUITY | ||
| Share capital | 8,818,762 | 8,818,762 |
| Share subscriptions receivable | (240) | (240) |
| Shares issuable (Note 5) | 96,006 | 80,956 |
| Share-based payment reserve | 1,337,829 | 1,337,829 |
| Deficit | (10,193,017) | (9,826,986) |
| TOTAL SOFTLAB9 TECHNOLOGIES INC. SHAREHOLDERS’ EQUITY | 59,340 | 410,321 |
| Non-controlling interest | (72,239) | (72,239) |
| TOTAL SHAREHOLDERS'EQUITY (DEFICIT) | (12,899) | 338,082 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 1,153,282 | 1,236,262 |
Nature of operations (Note 1) Subsequent event (Note 12)
Approved and authorized for issuance on behalf of the Board of Directors on August 26, 2021:
/s/ “Rahim Mohamed” /s/ “Derrick Lewis” Rahim Mohamed, Director Derrick Lewis, Director
(The accompanying notes are an integral part of these condensed consolidated financial statements)
3
Softlab9 Technologies Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss (Expressed in Canadian dollars) (unaudited)
| Three months | Three months | Six months | Six months | |
|---|---|---|---|---|
| ended | ended | ended | ended | |
| June 30, | June 30, | June 30, | June 30, | |
| 2021 | 2020 | 2020 | 2020 | |
| $ | $ | $ | $ | |
| EXPENSES | ||||
| Consulting and management fees (Note 8) | 95,000 | 443,025 | 197,000 | 524,705 |
| General and administrative | 121 | 10,353 | 208 | 11,600 |
| Investor relations | 18,732 | - | 18,732 | - |
| Professional fees (Note 8) | 43,631 | 51,127 | 132,098 | 57,165 |
| Transfer agent and filing fees | 1,637 | 47,722 | 17,993 | 54,470 |
| TOTAL EXPENSES | 159,121 | 552,227 | 366,031 | 647,940 |
| NET LOSS ATTRIBUTABLE TO SOFTLAB9 | ||||
| TECHNOLOGIES INC. | (159,121) | (552,227) | (366,031) | (647,940) |
| Loss per share attributed to Softlab9 | ||||
| Technologies Inc.,basic and diluted | (0.01) | (0.06) | (0.01) | (0.08) |
| Weighted average number of common shares | ||||
| outstanding | 17,496,851 | 8,764,924 | 26,128,435 | 8,509,647 |
(The accompanying notes are an integral part of these condensed consolidated financial statements)
4
Softlab9 Technologies Inc.
Condensed Consolidated Statements of Changes in Equity (Expressed in Canadian dollars) (unaudited)
| Share- | ||||||||
|---|---|---|---|---|---|---|---|---|
| Share | based | Non- | Total | |||||
| Number of | Share | subscriptions | Shares | payment | controlling | shareholders’ | ||
| common | capital | receivable | issuable | reserve | Deficit | interest | equity | |
| shares | $ | $ | $ | $ | $ | $ | $ | |
| Balance, December 31, 2019 | 8,251,565 | 5,640,025 | (16,800) | 1,147 | 1,232,253 | (7,474,729) | (72,239) | (690,343) |
| Shares issued from private | ||||||||
| placement | 3,159,215 | 1,105,725 | (734,070) | – | – | – | – | 1,839,795 |
| Shares issued from exercise of | ||||||||
| stock options | 40,000 | 9,088 | – | (4,288) | – | – | – | 4,800 |
| Net loss for the period | – | – | – | – | – | (647,940) | – | (647,940) |
| Balance,June 30,2020 | 8,251,565 | 5,640,025 | (16,800) | 1,147 | 1,232,253 | (7,570,442) | (72,239) | 506,312 |
| Balance, December 31, 2020 | 17,496,851 | 8,818,762 | (240) | 80,956 | 1,337,829 | (9,826,986) | (72,239) | 338,082 |
| Shares issuable to pay | ||||||||
| expenses on behalf of | ||||||||
| Cleango Greengo Inc. | – | – | – | 15,050 | – | – | – | 15,050 |
| Net loss for the period | – | – | – | – | – | (366,031) | – | (366,031) |
| Balance,June 30,2021 | 17,496,851 | 8,818,762 | (240) | 96,006 | 1,337,829 | (10,193,017) | (72,239) | (12,889) |
(The accompanying notes are an integral part of these condensed consolidated financial statements)
5
Softlab9 Technologies Inc.
Condensed Consolidated Statements of Cash Flows (Expressed in Canadian dollars) (unaudited)
| Softlab9 Technologies Inc. Condensed Consolidated Statements of Cash Flows (Expressed in Canadian dollars) (unaudited) |
|
|---|---|
| Six months ended June 30, 2021 $ |
Six months ended June 30, 2020 $ |
| OPERATING ACTIVITIES Net loss for the period (366,031) Changes in non-cash working capital items: Amounts receivable (16,315) Prepaid expenses and deposits 32,000 Accounts payable and accrued liabilities 268,001 Due to related parties – |
|
| (647,940) | |
| (699,716) | |
5,000 |
|
| (43,593) | |
7,405 |
|
| Net cash used in operating activities (82,345) |
|
| (1,378,844) | |
| INVESTING ACTIVITIES Loans receivable advances (15,050) |
|
| – | |
| Net cash used in investing activities (15,050) |
|
| – | |
| FINANCING ACTIVITIES Proceeds from exercise of stock options – Proceeds from issuance of shares – |
|
| 4,800 | |
| 1,694,055 | |
| Net provided in financing activities – Change in cash (97,395) Cash, beginning of period 141,134 |
|
| 1,698,855 | |
| 320,011 | |
| 7,148 | |
| Cash,end ofperiod 43,739 |
|
| 327,159 | |
| Non-cash investing and financing activities: Fair value of options exercised transferred to share capital – Shares issuable to pay expenses on behalf of Cleango Greengo Inc. included in loans receivable 15,050 |
|
| 4,288 | |
| – |
(The accompanying notes are an integral part of these condensed consolidated financial statements)
6
Softlab9 Technologies Inc. Notes to the Condensed Consolidated Financial Statements Three and Six Months Ended June 30, 2021 and 2020 (Expressed in Canadian dollars) (unaudited)
1. NATURE OF OPERATIONS AND GOING CONCERN
Softlab9 Technologies Inc. (formerly SoftLab9 Software Solutions Inc.) (the “Company”) is a start-up technology incubator, specializing in launching, acquiring, and vertically integrating technology companies. The Company incubates multiple mobile technologies internally while providing engineering, capital, executive management, and strategic development services The Company’s head office is located at suite 605 - 815 Hornby Street, Vancouver, BC, V6Z 2E6.
The Company was incorporated as CDN BVentures Ltd. on October 30, 2014 under the Business Corporations Act (British Columbia) as a wholly-owned subsidiary of a reporting issuer, Web Watcher Systems Ltd. (“Web Watcher”). On December 9, 2014, Web Watcher entered into an arrangement agreement (the “Arrangement Agreement”) with the Company. Under the terms of the Arrangement Agreement, Web Watcher was to complete a plan of arrangement which would divest Web Watcher of the asset consisting of a letter of intent, which would be divested to the Company for consideration of 960,234 common shares of the Company. Web Watcher received shareholder approval for the Arrangement Agreement at an annual general and special meeting of shareholders held on January 29, 2015 and received final approval to the Arrangement Agreement from the Supreme Court of British Columbia on February 5, 2015. The Arrangement Agreement was completed on October 24, 2017.
On October 26, 2017, the Company completed a share exchange agreement (the “Transaction”) with APPx Technologies Inc. (formerly Appature Technologies Inc.) (“ATI”). ATI was incorporated on December 31, 2007 under the laws of the province of British Columbia, Canada.
On March 2, 2018, the Company completed a share exchange agreement (the “Transaction”) with RewardDrop Software Inc. (“RSI”) was incorporated was incorporated under the Canada Business Corporation Act as a private company on August 22, 2017. Under the terms of the Transaction, the Company issued 2,564,102 common shares in exchange for 150 of issued and outstanding shares of RewardDrop Software Inc., which represents 100% ownership of RSI. As a result of the Transaction, the shareholders of RSI owned 68.2% of the Company.
On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant, but management continues to monitor the situation.
These condensed interim consolidated financial statements have been prepared on the assumption the Company will continue as a going concern. During the period ended June 30, 2021, the Company has not generated any revenues and incurred negative cash flows from operations. As at June 30, 2021, the Company has an accumulated deficit of $10,193,017. The Company intends to finance its current and future obligations and requirements through a combination of debt and/or equity issuances. These factors indicate existence of a material uncertainty that may cast doubt on the Company’s ability to continue as a going concern. These condensed interim consolidated financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.
2. SIGNIFICANT ACCOUNTING POLICIES
(a) Basis of Preparation
These condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards applicable to interim financial information, as outlined in International Accounting Standard (“IAS”) 34, “Interim Financial Reporting” and using the accounting policies consistent with those in the audited consolidated financial statements as at and for the year ended December 31, 2020.
These condensed interim consolidated financial statements do not include all disclosures normally provided in annual financial statements and should be read in conjunction with the annual consolidated financial statements as at and for the year ended December 31, 2020. Interim results are not necessarily indicative of the results expected for the fiscal year.
7
Softlab9 Technologies Inc. Notes to the Condensed Consolidated Financial Statements Three and Six Months Ended June 30, 2021 and 2020 (Expressed in Canadian dollars) (unaudited)
2. SIGNIFICANT ACCOUNTING POLICIES (continued)
- (b) Principles of Consolidation
These condensed interim consolidated financial statements include the accounts of the Company and its 90.56% owned subsidiary, ATI and ATI’s wholly-owned subsidiary, APPx Technologies Inc. (AB) and wholly owned subsidiary, RewardDrop Software Inc. All significant inter-company balances and transactions have been eliminated on consolidation.
- (c) Recent Accounting Pronouncements
The following IFRS standard has been recently issued by the IASB. Pronouncements that are not expected to have a significant impact have been excluded.
Amendments to IAS 1: Classification of Liabilities as Current or Non-current
The amendments to IAS 1 clarify the requirements relating to determining whether a liability should be presented as current or non-current in the statement of financial position. Under the new requirements, the assessment of whether a liability is presented as current or non-current is based on the contractual arrangements in place as at the reporting date and does not impact the amount or timing of recognition. The amendment applies retrospectively for annual reporting periods beginning on or after January 1, 2022. The Company is currently evaluating the potential impact of these amendments on the Company’s consolidated financial statements.
3. LOANS RECEIVABLE
-
(a) As at June 30, 2021, the Company has advanced $50,000 (2020 - $50,000) to Kosan Medical Company Ltd. The loan is non-interest bearing, secured by a general security agreement, and due on demand.
-
(b) As at June 30, 2021, the Company has advanced $928,526 (2020 – $898,426) to Cleango Greengo Inc. (“Cleango”). The loan will be forgiven upon closing the arrangement agreement with Cleango. Refer to Note 11. The loan is non-interest bearing, secured by a general security agreement over the assets of Cleango, and due on demand if the transaction does not complete for any reason other than a breach by the Company of an enforceable provision of the arrangement agreement.
4. LOANS PAYABLE
-
(a) As at June 30, 2021, the amount of $24,730 (December 31, 2020 - $24,730) is owed to a non-related company which is non-interest bearing, unsecured, and due on demand.
-
(b) As at June 30, 2021, the amount of $50,000 (December 31, 2020 - $50,000) is owed to a non-related party which is non-interest bearing, unsecured, and due on demand.
-
(c) As at June 30, 2021, the amount of $25,000 (December 31, 2020 - $25,000) is owed to the father of a former director of the Company which is non-interest bearing, unsecured, and due on demand.
5. SHARE CAPITAL
-
(a) On June 9, 2021, the Company entered into a debt settlement agreement on behalf of CleanGo whereby the Company agreed to settle a debt of $3,525 through the issuance of 8,813 units at $0.40 per unit. Each unit is to consist of one common share and one-half of a transferrable common share purchase warrant at $0.70 per share expiring 18 months from the date of issuance. As at June 30, 2021, the Company has not yet issued the units.
-
(b) On April 2, 2021, the Company entered into a debt settlement agreement on behalf of CleanGo whereby the Company agreed to settle a debt of $6,900 through the issuance of 17,250 units at $0.40 per unit. Each unit is to consist of one common share and one-half of a transferrable common share purchase warrant at $0.70 per share expiring 18 months from the date of issuance. As at June 30, 2021, the Company has not yet issued the units.
8
Softlab9 Technologies Inc.
Notes to the Condensed Consolidated Financial Statements Three and Six Months Ended June 30, 2021 and 2020 (Expressed in Canadian dollars) (unaudited)
5. SHARE CAPITAL (continued)
-
(c) On March 3, 2021, the Company entered into debt settlement agreement on behalf of CleanGo whereby the Company agreed to settle a debt of $4,625 through the issuance of 11,563 units at $0.40 per unit. Each unit is to consist of one common share and one-half of a transferrable common share purchase warrant exercisable at $0.70 per share expiring 18 months from the date of issuance. As at June 30, 2021, the Company has not yet issued the units.
-
(d) As at June 30, 2021, the Company has shares issuable of $96,006 (December 31, 2020 - $80,956).
6. SHARE PURCHASE WARRANTS
The following table summarizes the continuity of share purchase warrants:
| Weighted | |||||||
|---|---|---|---|---|---|---|---|
| average | |||||||
| exercise | |||||||
| Number of | price | ||||||
| warrants | $ | ||||||
| Balance,December | 31, | 2020 | and June | 30, | 2021 | 4,298,823 | 0.60 |
As at June 30, 2021, the following share purchase warrants were outstanding:
| Number of | Exercise | |
|---|---|---|
| warrants | price | |
| outstanding | $ | Expiry date |
| 1,589,610 | 0.60 | June 18, 2022 |
| 2,709,213 | 0.60 | July 21, 2022 |
| 4,298,823 |
7. STOCK OPTIONS
The following table summarizes the continuity of stock options:
| Weighted | ||
|---|---|---|
| average | ||
| exercise | ||
| Number of | price | |
| options | $ | |
| Balance, December 31, 2020 | 308,000 | 0.65 |
| Expired | (150,000) | 1.22 |
| Balance,June 30,2021 | 158,000 | 1.22 |
Additional information regarding stock options outstanding as at June 30, 2021 is as follows:
| Range of exercise prices $ |
Outstanding and exercisable |
|---|---|
| Number of options Weighted average remaining contractual life (years) Weighted average exercise price $ |
|
| 0.12 | 158,000 0.6 0.12 |
9
Softlab9 Technologies Inc. Notes to the Condensed Consolidated Financial Statements Three and Six Months Ended June 30, 2021 and 2020 (Expressed in Canadian dollars) (unaudited)
8. RELATED PARTY TRANSACTIONS
-
(a) During the six months ended June 30, 2021, the Company incurred $90,000 (2020 - $90,000) in consulting and management fees to a company controlled by the Chief Executive Officer of the Company (“CEO”). As at June 30, 2021, the Company owed $189,434 (December 31, 2020 - $94,934) to companies controlled by the CEO which are included in accounts payable and accrued liabilities. As at June 30, 2021, the Company also owed $500 (December 31, 2020 - $500) to the CEO which is non-interest bearing, unsecured, and due on demand.
-
(b) During the six months ended June 30, 2021, the Company incurred $21,000 (2020 - $31,300) in professional fees to a company controlled by the Chief Financial Officer (“CFO”) of the Company. As at June 30, 2021, the Company owed $22,050 (December 31, 2020 - $3,675) to a company controlled by the CFO which is included in accounts payable and accrued liabilities.
-
(c) As at June 30, 2021, the Company owed $27,531 (December 31, 2020 - $27,531) to the former President of the Company which is non-interest bearing, unsecured, and due on demand.
-
(d) As at June 30, 2020, the Company owed $40,920 (December 31, 2020 - $nil) to a director of the Company which is included in accounts payable and accrued liabilities.
9. MANAGEMENT OF CAPITAL
The Company’s objectives in managing capital are to ensure sufficient liquidity to finance its corporate administration and working capital. The Company manages its liquidity to minimize shareholder dilution whenever possible. The Company manages its capital through regular board meetings and ongoing review of consolidated financial information. The Company considers its capital as all components of shareholders’ equity.
The Company’s sources of capital have consisted of the sale of equity securities. In order for the Company to carry out planned acquisition, the Company will spend its working capital and expects to raise additional amounts externally as needed.
10. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
(a) Fair Values
Fair value measurements are classified using a fair value hierarchy that reflects the significance of inputs used in making the measurements. The fair value hierarchy has the following levels:
-
Level 1 - valuation based on quoted prices (unadjusted) in active markets for identical assets or liabilities;
-
Level 2 - valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and
-
Level 3 - valuation techniques using inputs for the asset or liability that are not based on observable market data (unobservable inputs).
The fair values of financial instruments, which includes cash, loans receivable, accounts payable and accrued liabilities, loans payable, and amounts due to related parties, approximate their carrying values due to the relatively short-term maturity of these instruments.
(b) Credit Risk
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. As at June 30, 2021, the Company’s exposure to credit risk is the carrying value of cash and loans receivable. The Company reduces its credit risk by holding its cash at a major Canadian financial institution. Loans receivable consist of advances made for potential business acquisitions and are secured by general security agreements. The carrying amount of financial assets represents the maximum credit exposure.
10
Softlab9 Technologies Inc. Notes to the Condensed Consolidated Financial Statements Three and Six Months Ended June 30, 2021 and 2020 (Expressed in Canadian dollars) (unaudited)
10. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (continued)
(c) Liquidity Risk
Liquidity risk is the risk that an entity will encounter difficulty in raising funds to meet commitments associated with financial instruments. To secure the additional capital necessary to pursue these plans, the Company may have to raise additional funds through equity or debt financing.
As at June 30, 2021, the Company had cash of $43,739 and accounts payable and accrued liabilities of $1,038,420. All accounts payable and accrued liabilities are due within 90 days.
- (d) Foreign Exchange Rate Risk
The Company is not exposed to any significant foreign exchange rate risk.
- (e) Interest Rate Risk
Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is not exposed to significant interest rate risk as it does not have any liabilities with variable rates.
11. PROPOSED TRANSACTION
On November 20, 2020, entered into a definitive agreement with Cleango for the acquisition of all of the issued and outstanding shares of Cleango (the “Transaction”). The Company is to issue 18,600,000 common shares of the Company to the shareholders of Cleango. An additional 5,400,000 common shares may be issued to certain shareholders of Cleango subject to the satisfaction of certain conditions. The Transaction is a “fundamental change” under Policy 8 of the Canadian Securities Exchange (“CSE”) and will be subject to receipt of all required regulatory, corporate, and third-party approvals, and the fulfillment of all applicable regulatory requirements and conditions necessary to complete the Transaction, including approval by the CSE and the shareholders of the Company and Cleango.
12. SUBSEQUENT EVENT
-
(a) On July 7, 2021, the Company entered into a debt settlement agreement on behalf of CleanGo whereby the Company agreed to settle a debt of $3,925 through the issuance of 9,813 units at $0.40 per unit. Each unit is to consist of one common share and one-half of a transferrable common share purchase warrant at $0.70 per share expiring 18 months from the date of issuance.
-
(b) Subsequent to the period ended June 30, 2021 has closed the first tranche of its previously announced, non-brokered private placement of securities for gross proceeds of $218,250 (see news release disseminated on Feb. 1, 2021, for more information about the offering).
The securities sold pursuant to this tranche of the offering consist of 545,625 units of the issuer at a price of 40 cents per unit. Each unit consists of one common share and one-half of a transferable common share purchase warrant. Each whole warrant will entitle the holder to purchase, for a period of 18 months from the date of issue, one additional common share of the issuer at an exercise price of 70 cents. The warrants are subject to an acceleration provision in favour of the company where the closing price of the common shares on the Canadian Securities Exchange for 10 consecutive trading days (or the average of the bid and ask prices if not traded) following the expiry of the four-month-and-one-day hold period equals or exceeds $1 per common share. Finders' fees of $8,330 were paid to qualified finders.
The net proceeds of the offering will be held in escrow and released to the company upon acceptance by the CSE of the company's acquisition of Clean Go Green Go Inc. (see news releases disseminated on Nov. 23, 2020, and Feb. 25, 2021, for additional information about the acquisition).
11
Softlab9 Technologies Inc.
Notes to the Condensed Consolidated Financial Statements Three and Six Months Ended June 30, 2021 and 2020 (Expressed in Canadian dollars) (unaudited)
- (c) Subsequent to the period ended June 30, 2021, the Company is pleased to announce that it has completed a second tranche of its private placement offering first announced in its news release of August 19, 2021. In this second tranche, the Company issued 1,954,374 units for gross proceeds of C$781,750. Each Unit consisted of one common share in the capital of the Company (“Share”) and one-half Share purchase warrant (“Warrant”). Each whole warrant will entitle the holder to purchase, for a period of 18 months from the date of issue, one additional common share of the Issuer at an exercise price of CAD $0.70 per common share. The warrants are subject to an acceleration provision in favour of the Company where the closing price of the common chares on the CSE for 10 consecutive trading days (or the average of the 'bid' and 'ask' prices if not traded) following the expiry of the four month and one day hold period equals or exceeds CAD$1.00 per common share.
The net proceeds of the offering will be held in escrow and released to the company upon acceptance by the CSE of the company's acquisition of Clean Go Green Go Inc.
12